Jamie C. Barner, Ph.D., FAACP, FAPhA

Jamie Barner

Division Head and Professor of Health Outcomes
Clifford L. Klinck, Jr. Centennial Professor

Research Interests

Research interests include:

1) examining the impact of pharmacy services (primarily medication therapy management services) on patient outcomes;

2) understanding factors that affect health care utilization and outcomes; and

3) examining the factors associated with medication adherence.

Publications

Makhinova T,* Barner JC, Brown CM, Rascati K, Richards K, Nag A, Rush SK, Pope ND, Barnes JN. Examination of barriers to medication adherence, asthma management, and control among community pharmacy patients with asthma. Journal of Pharmacy Practice 2018;9(3):215-226.

Singh-Gupte K,* Wilson J, Barner JC, Hovinga C, Rascati KL, Richards KM. Patterns of antiepileptic drug use in patients with potential refractory epilepsy in Texas Medicaid. Epilepsy & Behavior.2018;87:108-116.

Makhinova T,* Barner JC, Brown CM, Rascati K, Richards K, Nag A, Rush SK, Pope ND, Barnes JN. Adherence enhancement for patients with asthma in community pharmacy practice: tools development and pharmacists’ feedback. Forthcoming Journal of Pharmaceutical Health Services Research. 2018;9(3):215-226.

Nduaguba O,* Soremekun RO, Olugbake OA, Barner JC. The relationship between patient-related factors and medication adherence among Nigerian patients taking highly active antiretroviral therapy. African Health Sciences. 2017;17(3):738-74.

Thach AV,* Brown CM,  Herrera V, Sasane R, Barner JC Ford K, Lawson KA. Associations between treatment satisfaction, medication beliefs, and adherence to disease-modifying therapies in patients with multiple sclerosis. International Journal of MS Care. 2017;DOI:10.7224/1537-2073.2017-031.

Kim G,* Barner JC, Rascati KL, Richards K. Examining time to initiation of biologic disease-modifying antirheumatic drugs and medication adherence and persistence among Texas Medicaid recipients with rheumatoid arthritis. Clinical Therapeutics. 2016; 38(3):646-654.

Kim G,* Barner JC, Rascati KL, Richards K. Factors associated with the initiation of biologic disease modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis. Journal of Managed Care and Specialty Pharmacy. 2015;21(5):401-407.

Makhinova T,* Barner JC, Richards K, Rascati KL. Asthma controller medication adherence, risk of exacerbation, and use of rescue agents among Texas Medicaid patients with persistent asthma. Journal of Managed Care and Specialty Pharmacy. 2015;21(12):1124-1132.

Jiang S,* Barner JC, Park C, Ling Y. Treatment patterns of anti-vascular endothelial growth factor (VEGF) and laser therapy among patients with diabetic macular edema (DME). Journal of Managed Care and Specialty Pharmacy. 2015;21(9):735-741.

Jiang S,* Park C,* Barner JC. Ranibizumab for age-related macular degeneration: a meta-analysis of dose effects and comparison with no anti-VEGF treatment and bevacizumab. Journal of Clinical Pharmacy and Therapeutics. 2014;39(3):234-239.

Oladapo A,*Barner JC, Lawson KA, Novak S, Rascati KL, Richards K, Harrison DJ. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis. Journal of Managed Care and Specialty Pharmacy. 2014;20(7):657-667.

Oladapo AO,* Barner JC, Rascati KL, Scott SA. Examining adherence with medications used in treating diabetic peripheral neuropathic pain and their association with oral antidiabetic medication adherenceClinical Therapeutics. 2012;34(3):605-613.

Bailey GR,* Barner JC, Weems JK, Leckbee G, Solis R, Montemayor D, Pope ND. Assessing barriers to medication adherence in underserved patients with diabetes in Texas. The Diabetes Educator. 2012;38(2):271-279.

Khoza S,* Barner JC, Bohman T, Rascati K, Lawson K, Wilson J. Use of antidepressant agents and risk of type 2 diabetes. European Journal of Clinical Pharmacology. 2012;68(9):1295-1302.

Barner JC, Makhninova TV.* Economic implications of inhaler non-adherence in asthma and COPD in the USA. Proceedings of Respiratory Drug Delivery 2012, Davis Healthcare International: River Grove, IL, pp 261-270.

Khoza S,* Oladapo A,* Barner JC.  Adherence to medication for Attention Deficit/Hyperactivity Disorder (ADHD): Does time frame matter? Journal of Pharmaceutical Health Services Research. 2011;2(3):157-163.

Barner JC, Khoza S,* Oladapo AO.* ADHD medication use, adherence, persistence and cost among Texas Medicaid children.  Current Medical Research and Opinion. 2011;27:13-22.

Barner JC.  Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy to monotherapy and loose-dose combination therapy. Clinical Therapeutics. 2011;33:1281-1288.

*Denotes student(s) at the time of the study.

 

Presentations

Paranjpe R, Fleming ML, Johnson ML, Essien E, Barner JC, Serna O, Gallardo E, Ordonez N, Holstad MM, Abughosh SM, “Identifying adherence trajectories to angiotensin converting enzyme inhibitors/angiotensin receptor blockers among patients with comorbid diabetes & hypertension enrolled in a Medicare Advantage Plan (MAP),” at Academy of Managed Care Pharmacy Annual Meeting, Houston, TX, April 21-24, 2020.

Kang HA,* Barner JC, Rascati KL, Lawson KA, Mignacca RC, “Association between hydroxyurea medication adherence and all-cause and disease-related healthcare expenditures among Texas Medicaid enrollees with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2019.

Barner JC, Kang HA,* Richards K, Bhor M, Paulose J, Kutlar A, “Association between vaso-occlusive crises and opioid use among Texas Medicaid recipients with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2019.

Barner JC, Kang HA,* Richards K, Bhor M, Paulose J, Kutlar A, “Association between hydroxyurea adherence and persistence and vaso-occlusive crises among Texas Medicaid recipients with sickle cell disease” at Academy of Managed Care Pharmacy Annual Meeting, San Diego, CA, March 26-28, 2019.

Kang HA,* Barner JC, “Hydroxyurea medication adherence and opioid use among Texas Medicaid enrollees with sickle cell disease” at the American Pharmacists Association Annual Meeting, Seattle, WA, March 22-25, 2019.

Alshehri A,* Barner JC, Brown CM, Ford K, Rascati KL, Said A, “Diabetic Muslims patients’ medication use behavior and perceptions regarding collaboration with pharmacists during Ramadan” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Kang H,* Barner JC. “Pain medication (opioid and non-opioid) use among Texas Medicaid enrollees with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA , May 20-24, 2017.

Alshehri A,* Barner JC, Brown CM, Ford K, Rascati K, Atif S, Zabidi F, “Muslims and diabetes: health beliefs and medication usage during Ramadan” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Chimah C,* Brown CM, Barner JC, Chapman C, Walker H, “The effect of a tailored patient activation intervention in inflammatory bowel disease (IBD) patients – A Pilot Study” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Makhinova T,* Barner JC, Brown CM, Rascati K, Richards K, Nag A, Rush SK, Pope ND, Barnes JN, “Improving asthma management: patient-pharmacist partnership program in enhancing therapy adherence and asthma control” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Makhinova T,* Onduaguba S,* Barner JC, Roberson K, Richards K, “Texas Medicaid MTM pilot for patients with asthma and COPD: pharmacists’ interventions and return-on-investment” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Makhinova T,* Barner JC, Rush S, Wilson N. “Preparing student pharmacists for patient-focused counseling in asthma: addressing patient barriers to medication adherence” at the American Association of Colleges of Pharmacy National Meeting, Anaheim, CA, July 24-25, 2016.

Desai P,* Lawson KA, , Richards K, Rascati KL Barner JC, Miller A, “Assessing factors associated with antipsychotic polypharmacy in the Texas Medicaid population” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Maestri TJ,* Mican L, Rozea H, Barner JC, Thach A, Goruganthu D. “Do long-acting injectable antipsychotics prevent or delay hospital readmission?” at the College of Psychiatric and Neurologic Pharmacists Annual Meeting, Colorado Springs, CO, April 17-20, 2016.

Makhinova T,* Barner JC, Barnes JN, Wilson N, “’Development of an adherence enhancement program for patients with asthma in community pharmacy practice: instruments and pharmacists’ feedback” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Makhinova T,* Barner JC, Rush S, Wilson N. “Preparing student pharmacists for patient-focused counseling in asthma: addressing patient barriers to medication adherence” at the American Association of Colleges of Pharmacy National Meeting, Anaheim, CA, July 24-25, 2016.

Singh-Gupte K,* Wilson J, Barner JC, Hovinga C, Rascati KL, Richards KM, “Treatment patterns of antiepileptic drugs in patients with potential refractory epilepsy in the Texas Medicaid program” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Amuneke-Nze C,* Bamgbade B,*  Barner JC, “Examination of benefits and barriers of health management and medication adherence counseling among African American men” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Alsheri A,* Barner JC, Wong SL,* Qureshi S,* “Muslim patients’ medication use behaviors and perceptions regarding collaboration with pharmacists during Ramadan” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Gupte K,* Kim G,* Barner JC. “Impact of comorbid depressive disorder on medication adherence among Texas Medicaid patients with asthma” at the Academy of Managed Care Pharmacy Annual Meeting, Tampa, FL April 1-4, 2014.

Makhinova T,* Barner JC, Richards KM, Rascati KL. “Long-term controller medication adherence and use of short-acting β2-agonists (SABA) and oral corticosteroids (OCS) among Texas Medicaid patients with persistent asthma” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Montreal, QC, Canada, May 31-June 4, 2014.

Makhinova T,* Barner JC. “Medication adherence and use of oral corticosteroids among Texas Medicaid patients with persistent asthma” at the Academy of Managed Care Pharmacy Annual Meeting, Tampa, FL April 1-4, 2014.

Jiang S,* Barner JC, Park C,* Ling Y.* “Treatment patterns of anti-vascular endothelial growth factor (VEGF) and laser therapy among patients with diabetic macular edema (DME)” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Montreal, QC, Canada, May 31-June 4, 2014.

Jiang S,* Park C,* Barner JC. “Comparing treatment patterns and efficacy of ranibizumab for patients with age-related macular degeneration (AMD): a meta-analysis,” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2013.

Barner JC, Makhninova TV.* “Economic implications of inhaler non-adherence in asthma and COPD in the USA” at the Respiratory Drug Delivery Annual Conference, Phoenix, AZ May 14-17, 2012.

Oladapo AO,* Adeyemi AO,* Barner JC. “Comparing medication adherence, persistence and discontinuation rates to pregabalin and duloxetine among type 2 diabetic patients,” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC June 6-12, 2012.

Barner JC, Khoza S,* Oladapo A,* Lin C. “Adherence to medication for attention deficit hyperactivity disorder (ADHD):does the timeframe matter?” at the Taiwanese Society of Child and Adolescent Psychiatry, Taipei, Taiwan, May 31, 2011.

Khoza S,* Barner JC, Lawson K, Rascati K, Wilson J, Bohman T. “Use of antidepressants and the risk of diabetes mellitus: a nested case-control study” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 24, 2011.

Khoza S,* Barner JC, Lawson K, Rascati K, Wilson J, Bohman T. “Use of antidepressants and the risk of diabetes mellitus: A retrospective cohort study” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 24, 2011.

Oladapo AO,* Barner JC, Rascati KL, Strassels SA. “Examining adherence with medications used in treating diabetic peripheral neuropathic pain and their association with oral antidiabetic medication” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 24, 2011.

Bailey G,* Barner JC, Weems, Montemayor D, Pope N. “Assessing barriers to medication adherence in underserved diabetes patients in Texas” at the American Pharmacists Association Annual Meeting, Seattle, Washington, March 25-28, 2011.

*Denotes student(s) at the time of the study.

Publications

Nduaguba S,* Barner JC, Ford KL, Barnes JN, Lawson KA, Wilson J. Association between quality of care indicators for HIV infection and healthcare resource utilization and costsAIDS 2020;34(2):291-300.

Bamgbade BA,* Barner JC, Ford KH, Brown CM, Lawson WB, Burdine K. Addressing willingness to seek help for depression among African American college students: a study protocolJournal of Medical Internet Research 2020;9(2).

Amuneke-Nze CG,* Bamgbade B,* Barner JC. An investigation of health management perceptions and wellness behaviors in African American males in central Texas. American Journal of Men’s Health 2019;13(1).

Maestri TJ,* Mican L, Rozea H, Barner JC. Do long-acting injectable antipsychotics prevent or delay hospital readmission? Psychopharmacology Bulletin. 2018;48(1):1-8.

Barner JC, Petrilla AA, Kang HA,* Shen X, Alshehri A,* Sullivan E, Troeger K, Richards KM, Blackwell SC. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth. American Journal of Managed Care. 2017;23:S139-S146.

Kang HA,* Barner JC. The relationship between out-of-pocket healthcare expenditures and insurance status among individuals with Chronic Obstructive Pulmonary Disease. Journal of Pharmaceutical Health Services Research. 2017, DOI: 10.1111/jphs.12170.

Gupte K,* Kim G,* Barner JC. Impact of comorbid depression on medication adherence and asthma-related health care costs in Texas Medicaid patients with asthmaJournal of Pharmaceutical Health Services Research. 2015;6(4):197-205.

Park H,* Rascati K, Lawson KL, Barner JC, Richards K, Malone D. Health costs and outcomes associated with Medicare Part D prescription drug cost-sharing in beneficiaries on dialysis. Journal of Managed Care and Specialty Pharmacy. 2015;21(10):956-964.

Kim G,* Barner JC, Rascati KL, Richards K. Factors associated with the initiation of biologic disease modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis. Journal of Managed Care and Specialty Pharmacy. 2015;21(5):401-407.

Barner JC, Lawson KA, Roberson K, Makhinova T.* Clinical and Economic Outcomes of Texas Medicaid Medication Therapy Management (MTM) Pilot. Report for Texas Health and Human Services Commission. 2015.

Desai PR,* Lawson KA, Barner JC, Rascati KL. Estimating the direct and indirect costs for community-dwelling patients with schizophrenia. Journal of Pharmaceutical Health Services Research. 2013;4:187-194.

Desai P,* Lawson KL, Barner JC, Rascati KL. Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients. Journal of Managed Care Pharmacy. 2013;19(6):468-477.

*Denotes student(s) at the time of the study.

Presentations

Bamgbade B,* Barner JC, Brown CM, Ford K, Lawson W, “The impact of a culturally relevant psychoeducational intervention on depression health care seeking among African American college students” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Bamgbade B,* Barner JC, Brown CM, Ford K, Lawson W “Utilizing the Theory of Planned Behavior to understand depression help seeking beliefs and attitudes among African American college students” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Alshehri A,* Barner JC, Brown CM, Ford K, Rascati KL, Said A, “The relationship between Muslims’ perceptions of Islamophobia and perceived healthcare barriers” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Van Boskerck S,* Barner JC, Pope N, Comfort M, Stallings A, Murray M. “Impact and feasibility of implementing a systematic approach for medication therapy management in the community pharmacy setting: Pilot study expansion” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Nduaguba SO,* Chimah C,* Barner JC, Schnur K,* “Healthcare utilization and costs among post-menopausal women on adjuvant endocrine therapy” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA, May 20-24, 2017.

Park C*, Lawson KA, Barner JC, Powers DA, Rascati KL, Wilson JP. “Comorbidity measures to predict healthcare costs among elderly gynecologic cancer survivors in the US: an analysis of SEER-Medicare data” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA , May 20-24, 2017.

Park C*, Lawson KA, Barner JC, Powers DA, Rascati KL, Wilson JP. “Comorbidity measures to predict overall survival time among elderly gynecologic cancer survivors in the US: an analysis of SEER-Medicare data” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA , May 20-24, 2017.

Kanu CN,* Brown CM, Barner JC, Chapman CJ, Walker HA, “Patient activation in inflammatory bowel disease patients” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA, May 20-24, 2017.

Nduaguba SO,* Chimah C,* Barner JC, Schnur K,* “Healthcare utilization and costs among post-menopausal women on adjuvant endocrine therapy” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA, May 20-24, 2017.

Singh-Gupte K,* Wilson J, Barner JC, Hovinga C, Rascati KL, Richards KM, “Health care utilization and costs associated with potential refractory epilepsy in Texas Medicaid” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Singh-Gupte K,* Wilson J, Barner JC, Hovinga C, Rascati KL, Richards KM, “Treatment patterns of antiepileptic drugs in patients with potential refractory epilepsy in the Texas Medicaid program” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Singh R,* Lawson KL, Barner JC, Richards K, Sasane R, Wilson J, “Prevalence and incidence of attention deficit hyperactivity disorder among Texas Medicaid preschoolers” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Singh R,* Lawson KL, Barner JC, Richards K, Sasane R, Wilson J, “Treatment patterns in attention deficit hyperactivity disorder among Texas Medicaid preschoolers” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Singh R,* Lawson KL, Barner JC, Richards K, Sasane R, Wilson J, “Time-to-initiation, healthcare utilization, and costs of treatment of attention deficit hyperactivity disorder among Texas Medicaid preschoolers” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Smith SA,* Barner JC, Jokerst J, Srinivasa M, “Pharmacists’ interventions in community and ambulatory care practice settings: estimated cost avoidance (ECA) methodology and documentation analysis” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Singh-Gupte K,* Wilson J, Barner JC, Hovinga C, Rascati KL, Richards KM, “Health care utilization and costs associated with potential refractory epilepsy in Texas Medicaid” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Kang HA,* Barner JC. “Out-of-pocket healthcare expenditures among patients with chronic obstructive pulmonary disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Nduaguba O,* Sudhapalli P,* Barner JC. “Predictors of mammography screening among women aged 50-74” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Makhinova T,* Barner JC, Lawson KA, Roberson K. “Impact of medication therapy management (MTM) pilot program on healthcare utilization and costs among Texas Medicaid patients with hypertension” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Oladapo A,* Desai P,* Adeyemi A,* Barner JC. “Trends in attention deficit hyperactivity disorder medication use and expenditures in the United States: An analysis of 2000-2010 Medical Expenditure Panel data,” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2013.

Owusu Y,* Barner JC, Lawson K, Jokerst J, Lopez . “Incident coronary heart disease in type 2 diabetes mellitus patients: Is mean glycated hemoglobin a good predictor?” at the American Association of Colleges of Pharmacy National Meeting, San Antonio, TX, July 9-13, 2011.

*Denotes student(s) at the time of the study.

Integrative Clinical Practice, Pharmacy Practice, and Education

Publications

Dean T,* Bamgbade BA,* Barner JC, Rush S, Burdine K. Impact of a depression counseling intervention on student pharmacists’ confidence and comfort: A Pilot Study. Forthcoming Currents in Pharmacy Teaching and Learning. 12(4).

Kanu CN,* Brown CM, Barner JC, Chapman JC, Walker HD. The effect of a tailored patient activation intervention in patients with inflammatory bowel disease. Journal of Contemporary Pharmacy Practice. 2019;67(3):11-21.

Alshehri AM,* Barner JC, Rush S. The impact of a required course on third year pharmacy students’ perceived abilities and intentions in providing medication therapy management. Currents in Pharmacy Teaching and Learning. 2019;11(1):94-105.

Peterson J,* Barner JC, Lai P, Hinds A, Garza A, Nguyen M, Hill L, Gums T. Impact of physician-pharmacist co-visits at a primary care clinic in patients with uncontrolled diabetes. Journal of Pharmacy Practice. 2018 [epub ahead of print]

Murray M,* Barner JC, Pope N, Comfort M. Impact and feasibility of implementing a systematic approach for medication therapy management in the community pharmacy setting: A pilot study. Journal of Pharmacy Practice. 2018 [epub ahead of print]

Ogunsanya ME,* Brown CM, Odedina FT, Barner JC, Corbell B,* Adedipe T. Knowledge of prostate cancer and screening among young black men aged 18 to 40 years. American Journal of Men’s Health. 2017;11(4):1008-1018 DOI: 10.1177/1557988316689497.

Wong SL,* Barner JC, Sucic K, Nguyen M, Rascati KL. Integration of pharmacists into patient-centered medical homes (PCMHs) in federally qualified health centers in Texas. Journal of the American Pharmacists Association. 2017:57:375-381.

Varisco T,* Ogunsanya T,* Barner JC, Fleming M. Pharmacists’ perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management and patient outcomes. Journal of the American Pharmacists Association. 2017;57:S51-S62.

Bamgbade B,* Barner JC, Ford K. Evaluating the impact of an anti-stigma intervention on pharmacy students’ willingness to counsel people living with mental illness. Community Mental Health Journal. 2016; 53(5):525-533. DOI: 10.1007/s10597-016-0075-6.

Ogunsanya ME,* Brown CM, Odedina FT, Barner JC, Corbell B,* Adedipe T. Beliefs regarding prostate cancer screening among black males aged 18-40 years old. American Journal of Men’s Health. Epub ahead of print. DOI: 10.1177/1557988316637879.

Linedecker SJ,* Barner JC, Ridings-Myhra J, Garza A, Lopez D, McIntyre. Development of Direct Observation of Procedural Skills (DOPS) for fourth year pharmacy students in required ambulatory care rotations. American Journal of Health Systems Pharmacy 2016;1:73(5 Suppl 1):S57-62.

Thach A,* Brown CM, Barner JC, Shepherd M, Pope ND, Jiang S, Satasia J. Patients’ willingness to work with peer supporters for chronic medication management. Journal of Pharmaceutical Health Services Research. 2016; 7(1):81-88.

Koffarnus RL,* Mican LM, Lopez DA, Barner JCEvaluation of an inpatient psychiatric hospital physician education program and adherence to American Diabetes Association practice recommendations. American Journal of Health Systems Pharmacy. 2016;73(5 Suppl 1):S57-62. doi: 10.2146/sp150037.

Bamgbade B,* Ford K, Barner JC. Impact of a mental illness stigma awareness intervention on pharmacy student attitudes and knowledge.  American Journal of Pharmaceutical Education. 2016:80(5):Article 80.

Alshehri A,* Barner JC, Brown CM, Rush S. Medication and health problems and recommendations from MTM services provided by third year pharmacy students in community pharmacies. Currents in Pharmacy Teaching and Learning. 2015;7(1):70-77.

Peddaiahgari R,* Adeyemi A,* Barner JC, Lopez D, Jokerst J. A retrospective observational analysis of clinical outcomes before and after the publication of the AACE/ACE guidelines. International Journal of Clinical Medicine. 2014;5:717-723.

Padilla ME, Jiang S,* Barner JC, Rivera JO. Impact of community health center clinical pharmacists on vaccination rates among adult diabetic Latinos along the US-Mexico border. Journal of Pharmaceutical Health Services Research. 2014;5(3):175-180.

Gavaza P, Fleming M,* Barner JC. Examination of psychosocial predictors of Virginia pharmacists’ intention to utilize a prescription drug monitoring program using the theory of planned behavior. Research in Social and Administrative Pharmacy. 2014;10(2):448-458.

Fleming M,* Barner JC, Brown CM, Shepherd MD, Strassels S, Novak S. Pharmacists’ training, perceived roles and actions associated with dispensing controlled substance prescriptions. Journal of the American Pharmacists Association. 2014;54:241–250.

Kim-Romo D,* Barner JC, Brown CM, Rivera JO, Garza AA, Klein-Bradham K, Jokerst JR, Janiga X, Brown B . Spanish-speaking patients’ satisfaction with clinical pharmacists’ communication and demonstration of cultural sensitivity. Journal of the American Pharmacists Association. 2014;54:121-129.

Fleming M,* Barner JC, Brown CM, Shepherd MD, Strassels S, Novak S. Using the theory of planned behavior to examine pharmacists’ intention to utilize a prescription drug monitoring program database. Research in Social and Administrative Pharmacy. 2014;10(2):285-296.

Jiang S,* Bamgbade B,* Barner JC, Klein-Bradham K, Janiga X, Brown B. Impact of telephone and mail intervention on appointment adherence and clinical outcomes among patients with diabetes. Journal of Pharmaceutical Health Services Research. 2014;5:3-9.

Fleming ML,* Chandwani HS,* Barner JC, Weber SN,* Okoro TT.*  Prescribers’ and pharmacists’ requests for prescription monitoring program (PMP) data: Does PMP structure matter?  Journal of Pain and Palliative Care Pharmacotherapy. 2013;27(2):136-142.

Bailey GR,* Barner JC, Weems JK, Leckbee G, Solis R, Montemayor D, Pope ND. Assessing barriers to medication adherence in underserved patients with diabetes in Texas. The Diabetes Educator. 2012;38(2):271-279.

Bellone J,* Barner JC,  Lopez D. Post discharge interventions provided by pharmacists and the impact on hospital readmission rates.  Journal of the American Pharmacists Association. 2012;52(3):48-52.

Moczygemba LR, Barner JC, Gabrillo ER. 12 month outcomes of a Medicare Part D telephone medication therapy management programJournal of the American Pharmacists Association. 2012;52:6:e144-e152.

Moczygemba LR,* Barner JC, Lawson KA, Brown CM, Gabrillo ER, Godley P, Johnsrud M. The impact of telephone medication therapy management on medication and health-related problems, medication adherence and Medicare Part D drug costs: A 6-month follow-upThe American Journal of Geriatric Pharmacotherapy. 2011;9(5):328-338.

Fleming M,* Barner JC, Brown CM, Smith T.  Antidepressant treatment disparities: Implications for pharmacists.  Journal of the American Pharmacists Association. 2011;51(5):605-612.

*Denotes student(s) at the time of the study.

Presentations

Possidente C, Johnsrud M, McClain W, Colavecchia A, Hartman T, MacLean E, Richards K, Rascati K, Lawson K, Barner JC, “Development and assessment of a real world evidence (RWE) training program for pharmaceutical field medical professionals” at Academy of Managed Care Pharmacy Annual Meeting, Houston, TX, April 21-24, 2020.

Barner JC, Hughes PJ, Moczygemba LR, Pinto S, Sisson E, “Strategies for engaging community partners, healthcare professionals, and students: Research experiences from four institutions” at the American Association of Colleges of Pharmacy Annual Meeting, Long Beach, CA, July 18-20, 2020.

Moczygemba LR, Johnsrud M, Barner JC, Bingham J,A descriptive analysis of 2016 Medicare Part D medication therapy management comprehensive medication review completion rates” at the Academy of Managed Care Pharmacy Nexus Meeting, National Harbor, MD, October 29-November 1, 2019.

Merryweather-Arges P, Barner JC, Schommer J, Law A, Planas L, “Strategies and tools to engage patients as partners in the pharmacists’ patient care process,” at the American Association of Colleges of Pharmacy National Meeting, Chicago, IL, July 12-16, 2019.

Ameen M,* Biggs W,* Pope N, Barner JC, Rush S, Moczygemba L, Vogel S, “Development, implementation and evaluation of an interprofessional education program on pain management” at the American Pharmacists Association Annual Meeting, Seattle, WA, March 22-25, 2019.

Imarhia F,* Barner JC, Hill M, Rush S, “Pharmacy student provided medication therapy management: factors associated with medication and health-related problems” at the American Pharmacists Association Annual Meeting, Nashville, TN, March 16-19, 2018.

Imarhia FI,* Barner JC, Hill TM,* Akwari MK,* Jackson VS,* Carmouche PS,* Brown G,* “Value of medication management provided by pharmacy students” at the National Pharmaceutical Association/Student National Pharmaceutical Association National Convention Las Vegas, NV July 29‐Aug 1, 2017.

Kanu CN,* Brown CM, Barner JC, Chapman CJ, Walker HA, “Patient activation in inflammatory bowel disease patients” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA, May 20-24, 2017.

Peterson J, Barner JC, Lai P, Hinds A, Garza A, Nguyen M, Hill L, Gums T, “Impact of Physician-Pharmacist Co-visits at a Primary Care Clinic in Patients with Uncontrolled Diabetes” at the Alcáldé Southwest Leadership Conference, Galveston, TX,  April 26-27, 2017.

Makhinova T,* Barner JC, Brown CM, Rascati K, Richards K, Nag A, Rush SK, Pope ND, Barnes JN, “Improving asthma management: patient-pharmacist partnership program in enhancing therapy adherence and asthma control” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Makhinova T,* Onduaguba S,* Barner JC, Roberson K, Richards K, “Texas Medicaid MTM pilot for patients with asthma and COPD: pharmacists’ interventions and return-on-investment” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Alshehri A,* Barner JC, Brown CM, Ford K, Rascati K, Atif S, Zabidi F, “Muslim diabetic patients’ perceptions of pharmacist services and proposed pharmacist engagement activities during Ramadan” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Alshehri A,* Barner JC, Brown CM, Ford K, Rascati K, Atif S, Zabidi F, “Muslims and diabetes: health beliefs and medication usage during Ramadan” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Amuneke-Nze C,* Bamgbade B,* Barner JC, “Examination of black men’s attitudes and beliefs about medication management and pharmacists” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Pope N, Tillema M,* Barner JC, Comfort M. “Impact and feasibility of implementing a systematic approach for medication therapy management in the community pharmacy setting” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Dean T,* Bamgbade B,* Barner JC, Rush SK, Burdine K. “Impact of depression counseling intervention on student pharmacists’ confidence and comfortability: a pilot study” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Chimah C,* Brown CM, Barner JC, Chapman C, Walker H, “The effect of a tailored patient activation intervention in inflammatory bowel disease (IBD) patients – A Pilot Study” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Amuneke-Nze C,* Bamgbade B,*  Barner JC, “Examination of black males’ health management and perceptions” at the National Pharmaceutical Association/Student National Pharmaceutical Association National Convention, Atlanta, GA, July 29‐Aug 1, 2016.

Steele K,* Rush S, Barner JC, Pope N, Lawson K, Alsheri A,* “Development of a pharmacy technician training program to incorporate walk-in immunizations into the workflow of a community pharmacy” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Wong SL,* Barner JC, Nguyen M, Sucic K, “Integration of pharmacists into patient-centered medical homes (PCMHs)” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Varisco T,* Ogunsanya T,* Fleming M, Barner JC, “Pharmacists’ perceptions regarding the impact of hydrocodone rescheduling on workflow management, revenue, and patient outcomes” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Amuneke-Nze C,* Bamgbade B,*  Barner JC, “Examination of benefits and barriers of health management and medication adherence counseling among African American men” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Alshehri A,* Barner JC, Wong SL,* Qureshi S,* “Muslim patients’ medication use behaviors and perceptions regarding collaboration with pharmacists during Ramadan” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Makhinova T,* Barner JC, Rush S, Wilson N. “Preparing student pharmacists for patient-focused counseling in asthma: addressing patient barriers to medication adherence” at the American Association of Colleges of Pharmacy National Meeting, Anaheim, CA, July 24-25, 2016.

Wong SL,* Barner JC, Nguyen M, Sucic K, “Integration of pharmacists into patient-centered medical homes (PCMHs)” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Makhinova T,* Barner JC, Barnes JN, Wilson N, “’Development of an adherence enhancement program for patients with asthma in community pharmacy practice: instruments and pharmacists’ feedback” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Amuneke-Nze C,* Bamgbade B,*  Barner JC, “Examination of benefits and barriers of health management and medication adherence counseling among African American men” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Alsheri A,* Barner JC, Wong SL,* Qureshi S,* “Muslim patients’ medication use behaviors and perceptions regarding collaboration with pharmacists during Ramadan” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Smith SA,* Barner JC, Jokerst J, Srinivasa M, “Pharmacists’ interventions in community and ambulatory care practice settings: estimated cost avoidance (ECA) methodology and documentation analysis” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Rush S, Barner JC, Alsheri A.* “Developing a successful community pharmacy technician immunization training program to incorporate walk-in immunizations into the workflow of a community pharmacy” at the American Association of Colleges of Pharmacy National Meeting, National Harbor, MD, July 11-15, 2015.

Alsheri A,* Barner JC, Rush S. “Perceived abilities of third year pharmacy students in performing medication therapy management” at the American Association of Colleges of Pharmacy National Meeting, National Harbor, MD, July 11-15, 2015.

Alsheri A,* Barner JC, Rush S. “Perceived abilities of third year pharmacy students in performing medication therapy management” at the American Association of Colleges of Pharmacy National Meeting, Grapevine, TX, July 27-28, 2014.

Fleming M,* Barner JC, Brown CM, Shepherd MD, Strassels S, Novak S. “Texas community pharmacists’ views and actions regarding dispensing controlled prescription drugs,” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2013.

Fleming M,* Barner JC, Brown CM, Shepherd MD, Strassels S, Novak S. “Using the Theory of Planned Behavior to predict pharmacists’ intention to utilize a prescription drug monitoring program database” at the American Pharmacists Association Annual Meeting, Los Angeles, CA, March 1-4, 2013.

Alsheri A,* Barner JC, Rush S, Brown CM. “A course to teach third-year pharmacy students to provide medication therapy management in community pharmacies” at the American Association of Colleges of Pharmacy National Meeting, Chicago, IL, July 14-15, 2013.

Alsheri A,* Barner JC, Brown CM, Rush S. “Impact of third year pharmacy students providing medication therapy management in community pharmacies” at the American Pharmacists Association Annual Meeting, Los Angeles, CA, March 1-4, 2013.

Jiang S,* Bamgbade B,* Barner JC, Klein-Bradham K, Janiga X. “The impact of telephone and mail intervention on diabetes appointment keeping and clinical outcomes,” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC June 6-12, 2012.

Jiang S,* Padilla M, Barner JC, Hardamon V. “Community health center pharmacists’ impact on Latino immunization rates,” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC June 6-12, 2012.

Fleming ML,* Barner JC, LajideCL.* “Texas pharmacists’ beliefs regarding intention to utilize prescription drug monitoring program (PDMP) data” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC June 6-12, 2012.

Kim-Romo D,* Barner JC, Brown CM, Rivera JO, Garza AA, Klien-Bradham K, Janiga X, Jokerst JR, Brown B . “Spanish-Speaking patients’ satisfaction with clinical pharmacists’ communication skills and cultural sensitivity” at the American Pharmacists Association Annual Meeting, New Orleans, LA, March 9-12, 2012.

Peddaiahgari R,* Barner JC, Lopez D, Adeyemi A, Jokerst J. “A retrospective observational analysis of diabetes medication use and A1C before and after AACE/ACE guidelines” at the American Society of Health System Pharmacists Midyear Meeting, New Orleans, LA, December 4-8, 2011.

Moczygemba LR,* Barner JC, Gabrillo ER. “Twelve-month outcomes of a pharmacist-provided telephone medication therapy management (MTM) program” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 23, 2011.

*Denotes student(s) at the time of the study.

Contact Information
Phone:
Fax number:
512-471-8762
Campus location:
PHR 3.210D

US Mail Address:
UT College of Pharmacy-Health Outcomes and Pharmacy Practice
2409 University Avenue, STOP A1930
Austin, TX 78712-1120

FEDEX Address:
2409 University Avenue
PHR 3.210D
The University of Texas at Austin
Austin, TX 78712